3 results
8-K
EX-99.1
BLPH
Bellerophon Therapeutics, Inc.
9 Sep 15
Regulation FD Disclosure
12:00am
mortality rates resulting in a median survival of less than 5 years Only cure is lung transplantation More common in young women Approximately 20,000
10-K
2014 FY
EX-10.8
BLPH
Bellerophon Therapeutics, Inc.
31 Mar 15
Annual report
12:00am
· Negative pregnancy test for women of child-bearing potential, or surgically sterile, or post menopausal
· Acute MI defined as:
1. Typical rise … prior to MI
· Pregnant or lactating women; pregnancy confirmed by urine pregnancy test
STUDY DEVICE
ROUTE OF APPLICATION
Administered via intracoronary
S-1
EX-10.8
BLPH
Bellerophon Therapeutics, Inc.
13 Jan 15
IPO registration
12:00am
Maximum 30
MAIN INCLUSION CRITERIA
· Signed informed consent
· 18 to 75 years of age, inclusive
· Male or female
· Negative pregnancy test for women … women; pregnancy confirmed by urine pregnancy test
STUDY DEVICE
ROUTE OF APPLICATION
Administered via intracoronary (IC) injection, using multiple
- Prev
- 1
- Next